Picard Medical, Inc.
Data quality: 100%
PMI
NYSE
Manufacturing
Measuring & Analyzing Instruments
$0.94
▼
$0.05
(-4.65%)
Mkt Cap: 75.93 M
Price
$1.01
Mkt Cap
75.93 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Negative free cash flow of -15.67 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin-546.60%
Op. Margin-268.36%
Safety
Debt / Equity
N/A
Current Ratio2.16
Interest CoverageN/A
Valuation
PE (TTM)
-2.81
Below sector avg (-1.48)
P/B Ratio9.53
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -2.8 | -1.5 |
| P/B | 9.5 | 1.6 |
| ROE % | — | -53.4 |
| Net Margin % | -546.6 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 4.94 M | Net Income (TTM) | -27.00 M |
| ROE | N/A | ROA | -214.10% |
| Gross Margin | -4.13% | Operating Margin | -268.36% |
| Net Margin | -546.60% | Free Cash Flow (TTM) | -15.67 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.16 |
| Interest Coverage | N/A | Asset Turnover | 0.39 |
| Working Capital | 6.22 M | Tangible Book Value | 6.82 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -2.81 | Forward P/E | N/A |
| P/B Ratio | 9.53 | P/S Ratio | 15.37 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -20.64% | ||
| Market Cap | 75.93 M | Enterprise Value | 73.12 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | 0.07 |
| FCF / Share | -0.21 | OCF / Share | -0.21 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 58.04% |
| SBC-Adj. FCF | -16.43 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 |
|---|---|
| Revenue | 4.94 M |
| Net Income | -27.00 M |
| EPS (Diluted) | — |
| Gross Profit | -204,000.0 |
| Operating Income | -13.26 M |
| EBITDA | — |
| R&D Expenses | 3.05 M |
| SG&A Expenses | 10.00 M |
| D&A | 163,000.0 |
| Interest Expense | — |
| Income Tax | 35,000.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 |
|---|---|
| Total Assets | 22.55 M |
| Total Liabilities | 18.76 M |
| Shareholders' Equity | 3.79 M |
| Total Debt | — |
| Cash & Equivalents | 7.45 M |
| Current Assets | 20.73 M |
| Current Liabilities | 18.70 M |
{"event":"ticker_viewed","properties":{"ticker":"PMI","listing_kind":"stock","pathname":"/stocks/pmi","exchange":"NYSE","country":"US"}}